AMP:NYSE
Ameriprise Financial, Inc.
Data as of 2026-03-10 - not real-time
$461.48
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ameriprise Financial shows a clear disconnect between its technical outlook and its underlying fundamentals. On the chart, price is trading below both short‑ and medium‑term moving averages, MACD is in a bearish configuration and volume is tapering, suggesting short‑term pressure toward the identified support zone. Yet the company delivers robust profitability, a trailing P/E well under the industry average, a strong ROE, and a low payout ratio that makes the dividend highly sustainable.
The valuation gap – with a discounted cash‑flow estimate far above the current market price – combined with solid cash generation and modest leverage points to a compelling buying opportunity for investors with a medium to long horizon. A disciplined approach that respects the near‑term support level while capitalizing on the undervaluation and dividend safety is advisable.
The valuation gap – with a discounted cash‑flow estimate far above the current market price – combined with solid cash generation and modest leverage points to a compelling buying opportunity for investors with a medium to long horizon. A disciplined approach that respects the near‑term support level while capitalizing on the undervaluation and dividend safety is advisable.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- Bearish technical momentum with price below key moving averages
- Proximity to a defined support level
- Decreasing trading volume indicating limited short‑term buying pressure
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Significant valuation upside relative to DCF fair value
- Strong return on equity and consistent cash flow generation
- Sustainable dividend supported by low payout ratio
Long Term
> 3 yearsbuy
Conviction: 9/10
Key Factors
- Durable competitive advantages in wealth and asset management
- Continued earnings growth potential and high profitability margins
- Attractive dividend yield combined with ample balance‑sheet strength
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin18.84%
P/E Ratio12.7
ROE60.51%
ROA2.27%
Debt/Equity57.60
P/B Ratio6.4
Op. Cash Flow$8.3B
Free Cash Flow$3.6B
Industry P/E17.4
Technical Analysis
TrendBearish
RSI40.9
Support$445.00
Resistance$545.35
MA 20$476.35
MA 50$495.95
MA 200$496.85
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Fair Value$834.55
Target Price$570.00
Upside/Downside23.52%
GradeUndervalued
TypeBlend
Dividend Yield1.39%
Risk Assessment
Beta1.17
Volatility38.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.